---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-22-000120"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2022-08-02T23:59:59+00:00"
generated_at: "2026-06-24T05:57:55.018486+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners Q2 revenue up 13.3% to $615.4M; Adj EBITDA up 13.4% to $86.1M

## Summary
- Revenue $615.4M vs $543.3M; net loss $18.4M vs $26.9M in prior year quarter.
- Days adjusted same-facility revenues up 6.9%; cases +1.9%, revenue per case +4.9%.
- Adj EBITDA ex-CARES grants up 17.8% to $86.0M; margin 14.0%.
- 2022 guidance reaffirmed: revenue $2.5-2.6B, Adj EBITDA $375-385M.
- Deployed ~$90M in six acquisitions at ~7x average multiple; liquidity $227.4M cash plus $203M revolver.

## SEC filing metadata
- accession: 0001638833-22-000120
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2022-08-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883322000120/0001638833-22-000120-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883322000120/sgry-20220802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-22-000120
- JSON: https://secwatch.observer/filing/0001638833-22-000120.json
- Plain text: https://secwatch.observer/filing/0001638833-22-000120.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.